Stock listing

OTC:THER Theralink Technologies Inc. Stock

Follow Theralink Technologies Inc. into a list and get an email when it puts out news.

Share price · OTC:THER

$0.0001 USD 0.0000 (0.0%)

Close on Oct 13, 2026 · Data provided by Twelve Data

Theralink Technologies Inc. logo
Ticker
OTC:THER
Asset type
Stock
Exchange
OTC
Currency
USD

Latest news

OncBioMune Initiates Phase 2 Clinical Trial of Novel Vaccine as Front-Line Treatment for Prostate Cancer

Sep 27, 2018

OncBioMune’s Phase 2 Clinical Trial of ProscaVax for Early-Stage Prostate Cancer is Now Included on ClinicalTrials.gov

Jul 9, 2018

OncBioMune Signs Work Order for Phase 2 Clinical Trial of ProscaVax for Early Stage Prostate Cancer

Jul 2, 2018

OncBioMune to Commence Phase 2 Trial of ProscaVax for Early Stage Prostate Cancer Patients

Jun 20, 2018

OTC Markets Group Announces Lists of Compliance Downgrades and Caveat Emptor Designations for the Month of May

Jun 6, 2018

OncBioMune Returns Protocol to Scientific Review Committee Overseeing Phase 2 Prostate Cancer Clinical Trial

Mar 28, 2018

Scientific Review Committee Meets on OncBioMune’s Phase 2 Prostate Cancer Clinical Trial

Mar 22, 2018

OncBioMune Announces Presentation at the 2018 AACR Annual Meeting

Mar 20, 2018

OncBioMune Appoints Robert Neal Holcomb to Board of Directors

Mar 19, 2018

OncBioMune Selects Theradex as CRO for Two Phase 2 Trials of ProscaVax for Prostate Cancer

Mar 8, 2018

All Theralink Technologies Inc. news

Decks

Theralink Technologies Inc. on 6ix

News releases
98 in all · newest Sep 27, 2018 · oldest 2015
Decks
2 decks · latest Oct 29, 2020

Log in to ask 6ix AI your own questions about Theralink Technologies Inc.